nach oben

Current Breast Cancer Reports

Erschienen in:

Open Access 27.06.2016 | Clinical Trials (S Hurvitz, Section Editor)

Reducing the Risk of Breast Cancer Recurrence: an Evaluation of the Effects and Mechanisms of Diet and Exercise

verfasst von: Christina M. Dieli-Conwright, Kyuwan Lee, Jacqueline L. Kiwata

Erschienen in: Current Breast Cancer Reports | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

With recent medical advances in diagnosis and treatment, the increasing numbers of long-term survivors of breast cancer is considerable and has resulted in the expansion of scientific research to include examination of lifestyle modifications as means of prevention of recurrence, new breast cancer events, and mortality. The objective of this report is to review randomized controlled trials (RCTs) including diet and/or exercise interventions on breast cancer recurrence in women with a history of breast cancer as well as pertinent recent epidemiologic evidence. Implicated biologic mechanisms are discussed to elucidate the impact of diet and exercise on disease recurrence.

Siegel RL, Miller KD, Jemal A. Cancer statistics. Ca-Cancer J Clin. 2015;65(1):5–29.CrossRefPubMed

Demark-Wahnefried W, Campbell KL, Hayes SC. Weight management and its role in breast cancer rehabilitation. Cancer. 2012;118(8 Suppl):2277–87.CrossRefPubMed

Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011;105 Suppl 1:S52–73.CrossRefPubMedPubMedCentral

Marmot M, Atinmo T, Byers T, Chen J, Hirohata T, Jackson A, James W, Kolonel L, Kumanyika S, Leitzmann C: Food, nutrition, physical activity, and the prevention of cancer: a global perspective. 2007

Patterson RE, Cadmus LA, Emond JA, Pierce JP. Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas. 2010;66(1):5–15.CrossRefPubMed

Rock CL, Doyle C, Demark‐Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):242–74.CrossRef

Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst. 2006;98(24):1767–76.CrossRefPubMed

Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial. Jama. 2007;298(3):289–98.CrossRefPubMedPubMedCentral

Chlebowski R, Blackburn G, Hoy M, Thomson C, Giuliano A, McAndrew P, Hudis C, Butler J, Shapiro A, Elashoff R: Survival analyses from the Women’s Intervention Nutrition Study (WINS) evaluating dietary fat reduction and breast cancer outcome. In: ASCO Annual Meeting Proceedings: 2008; 2008: 522

10.

Cohen DH, LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer. 2012;19(5):F27–45.CrossRefPubMed

11.

Howe LR, Subbaramaiah K, Hudis CA, Dannenberg AJ. Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res. 2013;19(22):6074–83.CrossRefPubMedPubMedCentral

12.

Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10(3):181–93.CrossRefPubMedPubMedCentral

13.•

Belardi V, Gallagher EJ, Novosyadlyy R, LeRoith D. Insulin and IGFs in obesity-related breast cancer. J Mammary Gland Biol Neoplasia. 2013;18(3-4):277–89. This review discusses the role of the insulin-family hormones, factors and receptors in obesity-associated tumor progression and metastases in breast cancer. CrossRefPubMed

14.

Werner H. Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer. Oncogene. 2012;31(22):2703–14.CrossRefPubMed

15.

Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Stratford AL, et al. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res. 2008;68(24):10238–46.CrossRefPubMed

16.

Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95(3):727–48.CrossRefPubMedPubMedCentral

17.

Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004;114(4):569–81.CrossRefPubMedPubMedCentral

18.

Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila). 2011;4(7):1021–9.CrossRef

19.

Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene. 2009;28(33):2940–7.CrossRefPubMed

20.

Subbaramaiah K, Morris PG, Zhou XK, Morrow M, Du B, Giri D, et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer discovery. 2012;2(4):356–65.CrossRefPubMedPubMedCentral

21.

Zhou J, Suzuki T, Kovacic A, Saito R, Miki Y, Ishida T, et al. Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer. Cancer Res. 2005;65(2):657–63.PubMed

22.

Vadodkar AS, Suman S, Lakshmanaswamy R, Damodaran C. Chemoprevention of breast cancer by dietary compounds. Anti Cancer Agents Med Chem. 2012;12(10):1185–202.CrossRef

23.

Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin GA, Caan BJ, et al. Dietary pattern influences breast cancer prognosis in women without hot flashes: the women’s healthy eating and living trial. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(3):352–9.CrossRef

24.

Rock CL, Flatt SW, Laughlin GA, Gold EB, Thomson CA, Natarajan L, et al. Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Am Soc Prev Oncol. 2008;17(3):614–20.CrossRef

25.

Thomson CA, Rock CL, Thompson PA, Caan BJ, Cussler E, Flatt SW, et al. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study. Breast Cancer Res Treat. 2011;125(2):519–27.CrossRefPubMed

26.

Nahum A, Zeller L, Danilenko M, Prall OW, Watts CK, Sutherland RL, et al. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur J Nutr. 2006;45(5):275–82.CrossRefPubMed

27.

Hirsch K, Atzmon A, Danilenko M, Levy J, Sharoni Y. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells. Breast Cancer Res Treat. 2007;104(2):221–30.CrossRefPubMed

28.

Rock CL, Flatt SW, Thomson CA, Stefanick ML, Newman VA, Jones LA, et al. Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22(12):2379–87.CrossRef

29.

Kendall ME, Cohen LA. Effect of dietary fiber on mammary tumorigenesis, estrogen metabolism, and lipid excretion in female rats. In Vivo. 1992;6(3):239–46.PubMed

30.

Caan BJ, Natarajan L, Parker B, Gold EB, Thomson C, Newman V, et al. Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Am Soc Prev Oncol. 2011;20(5):854–8.CrossRef

31.

Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, et al. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol biomarkers Prev Publ Am Assoc Cancer Res Am Soc Prev Oncol. 2007;16(11):2285–92.CrossRef

32.

Guha N, Kwan ML, Quesenberry Jr CP, Weltzien EK, Castillo AL, Caan BJ. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2009;118(2):395–405.CrossRefPubMedPubMedCentral

33.

Nechuta SJ, Caan BJ, Chen WY, Lu W, Chen Z, Kwan ML, et al. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr. 2012;96(1):123–32.CrossRefPubMedPubMedCentral

34.

Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, et al. Soy food intake and breast cancer survival. Jama. 2009;302(22):2437–43.CrossRefPubMedPubMedCentral

35.

Taylor CK, Levy RM, Elliott JC, Burnett BP. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev. 2009;67(7):398–415.CrossRefPubMed

36.

Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis. 1995;16(11):2833–40.CrossRefPubMed

37.

Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB, Chambers AF. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res. 2005;65(8):3396–403.PubMed

38.

Jacobs ET, Thomson CA, Flatt SW, Al-Delaimy WK, Hibler EA, Jones LA, et al. Vitamin D and breast cancer recurrence in the Women’s Healthy Eating and Living (WHEL) Study. Am J Clin Nutr. 2011;93(1):108–17.CrossRefPubMed

39.

Clark AS, Chen J, Kapoor S, Friedman C, Mies C, Esserman L, et al. Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657). Cancer Med. 2014;3(3):693–701.CrossRefPubMedPubMedCentral

40.•

Lohmann AE, Chapman JA, Burnell MJ, Levine MN, Tsvetkova E, Pritchard KI, et al. Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer. Breast Cancer Res Treat. 2015;150(3):605–11. This observational study nested in a phase III adjuvant trial examined the association between vitamin D levels and measures of recurrence and survival in breast cancer survivors. They reported no association between vitamin D level and any outcome. CrossRefPubMed

41.

Pritchard KI, Shepherd LE, Chapman JA, Norris BD, Cantin J, Goss PE, et al. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(29):3869–76.CrossRef

42.

Krishnan AV, Swami S, Feldman D. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol. 2010;121(1-2):343–8.CrossRefPubMed

43.

Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(23):3757–63.CrossRef

44.

Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast cancer research : BCR. 2011;13(4):R74.CrossRefPubMedPubMedCentral

45.

Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults a scientific statement from the American Heart Association. Circulation. 2010;122(4):406–41.CrossRefPubMed

46.

Arnold M, Leitzmann M, Freisling H, Bray F, Romieu I, Renehan A, et al. Obesity and cancer: an update of the global impact. Cancer Epidemiol. 2016;41:8–15.CrossRefPubMed

47.

Noguchi JL, Liss MA, Parsons JK: Obesity, Physical Activity and Bladder Cancer. Curr Urol Rep 2015, 16(10).

48.

Hartman SJ, Marinac C, Natarajan L, Patterson R. Obesity, physical activity, and sleep may impact cognitive functioning in breast cancer survivors. Ann Behav Med. 2014;47:S237.

49.

Lee JK, So KA, Piyathilake CJ, Kim MK: Mild Obesity, Physical Activity, Calorie Intake, and the Risks of Cervical Intraepithelial Neoplasia and Cervical Cancer. PloS one 2013, 8(6).

50.

Martin E, Bulsara C, Battaglini C, Hands B, Naumann FL. Breast and prostate cancer survivor responses to group exercise and supportive group psychotherapy. J Psychosoc Oncol. 2015;33(6):620–34.CrossRefPubMed

51.

Falzon C, Radel R, Cantor A, d’Arripe-Longueville F. Understanding narrative effects in physical activity promotion: the influence of breast cancer survivor testimony on exercise beliefs, self-efficacy, and intention in breast cancer patients. Support Care Cancer. 2015;23(3):761–8.CrossRefPubMed

52.

Klika RJ, Callahan KE, Golik KS. Exercise capacity of a breast cancer survivor: a case study. Med Sci Sports Exerc. 2008;40(10):1711–6.CrossRefPubMed

53.

Loprinzi PD, Cardinal BJ, Winters-Stone K, Smit E, Loprinzi CL. Physical activity and the risk of breast cancer recurrence: a literature review. Oncol Nurs Forum. 2012;39(3):269–74.CrossRefPubMed

54.•

Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635–54. This systematic review and meta-analysis is the most recent and thorough evaluation of physical activity and its effects on breast cancer outcomes, including 22 prospective studies. CrossRefPubMed

55.

Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. Jama-J Am Med Assoc. 2005;293(20):2479–86.CrossRef

56.••

Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM, et al. Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc. 2014;46(9):1744–51. This multicenter RCT is the first trial to examine the effects of exercise on breast cancer outcomes and further demonstrated that exercise may improve these outcomes. CrossRefPubMed

57.

Dieli-Conwright CM, Mortimer JE, Schroeder ET, Courneya K, Demark-Wahnefried W, Buchanan TA, et al. Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods. BMC Cancer. 2014;14:238.CrossRefPubMedPubMedCentral

58.

McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer. 2008;8(3):205–11.CrossRefPubMed

59.

Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care. 2003;26(11):2977–82.CrossRefPubMed

60.

Rock CL, Pande C, Flatt SW, Ying C, Pakiz B, Parker BA, et al. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese. Clin Breast Cancer. 2013;13(3):188–95.CrossRefPubMedPubMedCentral

61.

Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors a randomized controlled trial. Cancer Epidemiol Biomark. 2003;12(8):721–7.

62.

Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomark. 2009;18(1):306–13.CrossRef

63.

Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol. 2008;26(6):907–12.CrossRefPubMed

64.

Schmitz KH, Ahmed RL, Hannan PJ, Yee D. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomark. 2005;14(7):1672–80.CrossRef

65.

Macciò A, Madeddu C, Gramignano G, Mulas C, Floris C, Massa D, et al. Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications. J Mol Med. 2010;88(7):677–86.CrossRefPubMed

66.••

Schmidt S, Monk J, Robinson L, Mourtzakis M. The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise. Obes Rev. 2015;16(6):473–87. This recent review discusses plausible mechanisms underlying the relationship between leptin and obesity, and how energy expenditure through exercise can mediate their interaction. CrossRefPubMedPubMedCentral

67.

Rogers LQ, Fogleman A, Trammell R, Hopkins-Price P, Vicari S, Rao K, Edson B, Verhulst S, Courneya KS, Hoelzer K: Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integrative cancer therapies 2012:1534735412449687

68.

Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26.CrossRefPubMed

69.

Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, et al. American cancer society guidelines on nutrition and physical activity for cancer prevention reducing the risk of cancer with healthy food choices and physical activity. Ca-Cancer J Clin. 2012;62(1):30–67.CrossRefPubMed

70.

Committee PAGA. Physical activity guidelines advisory committee report. Washington, DC: US Department of Health and Human Services; 2008.

71.••

Rock CL, Flatt SW, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, et al. Results of the exercise and nutrition to enhance recovery and good health for you (ENERGY) trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(28):3169–76. The ENERGY RCT is the largest weight loss intervention trial among breast cancer survivors and demonstrated that a behavioral weight loss intervention can be effective at reducing body weight and circulating levels of estrogens and cytokines implicated in recurrence. CrossRef

72.

Scott E, Daley AJ, Doll H, Woodroofe N, Coleman RE, Mutrie N, et al. Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: a randomized controlled trial. Cancer Causes Control : CCC. 2013;24(1):181–91.CrossRefPubMed

73.

Villarini A, Pasanisi P, Traina A, Mano MP, Bonanni B, Panico S, et al. Lifestyle and breast cancer recurrences: the DIANA-5 trial. Tumori. 2012;98(1):1–18.PubMed

74.

Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clinical Oncol Off J Am Soc Clin Oncol. 2007;25(17):2345–51.CrossRef

75.

Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol Off J Am Socc Clin Oncol. 2002;20(4):1128–43.CrossRef

76.

Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat. 2008;111(2):329–42.CrossRefPubMed

Titel: Reducing the Risk of Breast Cancer Recurrence: an Evaluation of the Effects and Mechanisms of Diet and Exercise
verfasst von: Christina M. Dieli-Conwright
Kyuwan Lee
Jacqueline L. Kiwata
Publikationsdatum: 27.06.2016
Verlag: Springer US
Erschienen in: Current Breast Cancer Reports / Ausgabe 3/2016
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI: https://doi.org/10.1007/s12609-016-0218-3

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Reducing the Risk of Breast Cancer Recurrence: an Evaluation of the Effects and Mechanisms of Diet and Exercise

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

Aromatase Inhibitor-Associated Arthralgia: How Big Is the Problem and What Can Be Done?

Screening for Cognitive Impairment Associated with Chemotherapy for Breast Cancer

Current Approach to Breast Cancer Risk Reduction for Women with Hereditary Predispositions to Breast Cancer

Update on Breast Cancer Risk Reduction Therapy

Physician and Patient Barriers to Breast Cancer Preventive Therapy

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie